SCHEMBL17875875

SCHEMBL17875875

c1ccc(-c2cc(-c3ccc4c(c3)COCc3ccc(-c5cc(-c6ccccc6)nc(-c6ccccc6)c5)cc3-4)cc(-c3ccccc3)n2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.36
KMT2A Q03164 6/20 0.36
MEN1 O00255 5/20 0.36
TDP2 O95551 1/20 0.36
THRB P10828 1/20 0.36
MYC P01106 1/20 0.36
PARP10 Q53GL7 1/20 0.35
PARP11 Q9NR21 1/20 0.35
MAPT P10636 6/20 0.35
ALDH1A1 P00352 4/20 0.35
HPGD P15428 4/20 0.35
KDM4E B2RXH2 3/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
MAPK1 P28482 2/20 0.35
TDP1 Q9NUW8 1/20 0.35
HSP90AA1 P07900 1/20 0.34
RAB9A P51151 1/20 0.34
ADORA2A P29274 1/20 0.34
ADORA1 P30542 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17875861 0.97 CYP19A1 (0.38) CYP19A1KMT2AMEN1TDP2THRB
SCHEMBL17875878 0.97 CYP19A1 (0.38) CYP19A1KMT2AMEN1TDP2THRB
SCHEMBL17875905 0.94 CYP19A1 (0.40) CYP19A1KMT2AMEN1THRBMYC
SCHEMBL17875904 0.91 CYP19A1 (0.41) CYP19A1KMT2AMEN1THRBMYC
SCHEMBL17875870 0.89 CYP19A1 (0.50) CYP19A1TDP2KDM4E
SCHEMBL17875877 0.89 CYP19A1 (0.50) CYP19A1TDP2KDM4E
SCHEMBL17875840 0.87 PLA2G2A (0.34) KMT2AMEN1MAPTALDH1A1HPGD
SCHEMBL17875836 0.87 HCRTR1 (0.34) KMT2AMEN1MAPTALDH1A1HPGD
SCHEMBL17875874 0.87 PLA2G2A (0.34) KMT2AMEN1MAPTALDH1A1HPGD
SCHEMBL17875873 0.87 HCRTR1 (0.34) KMT2AMEN1MAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 CYP19A1 167/4885KMT2A 1757/4885MEN1 448/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 CYP19A1 167/4885KMT2A 1757/4885MEN1 448/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.